Study of BEBT-109 in Subjects With EGFR Exon 20 Insertion Mutations Non-Small Cell Lung Cancer

Clinical trial NCT06706713 · RECRUITING

Trial details

NCT number: NCT06706713
Sponsor: BeBetter Med Inc
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer EGFR Exon 20 Insertion Mutation

Start date: 2022-04-15
Primary completion: 2025-12-31
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.